BlossomHill Therapeutics (BLSM) Stock News

$BLSM · NASDAQ · 1 stories in 30 days

BORSA has published 1 story on BlossomHill Therapeutics (BLSM) in the past 30 days.

The wire on $BLSM

newest first · updated Sep 20, 11:21 PM ET · direct subject stories only

Analyst actionSep 20 · 11:21 PM ET

BlossomHill Therapeutics target raised to $40 by Guggenheim

BlossomHill Therapeutics target raised to $40 by Guggenheim.

bullish 65 · impact 30

An editorial illustration showing a laboratory beaker being measured by large calipers to a new, higher level.

FREE ACCOUNT · 3 COMPLETE TICKER VIEWS A DAY

The wire on this name is open. What the tape did about it is one free account away.

One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.

BORSAPLUSNews on Price · Earnings read · Flow and ownership · Options context

Create a free account · no card

Horizon	Coverage	Vs SPY match	Vs sector match	Stock median	Vs SPY median	Vs sector median
1 hour	0 measured · 0 days · 0 pending · 10 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—
Next session close	0 measured · 0 days · 0 pending · 10 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—
Fifth subsequent session close	0 measured · 0 days · 0 pending · 10 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—

BlossomHill Therapeutics (BLSM) Stock News

The wire on $BLSM

The wire on this name is open. What the tape did about it is one free account away.

BlossomHill Therapeutics (BLSM) Stock News

The wire on $BLSM

The wire on this name is open. What the tape did about it is one free account away.

BlossomHill Therapeutics (BLSM) stock: common questions

What is the latest BlossomHill Therapeutics stock news?

Frozen company-score outcomes